Icosapent Ethyl
Who holds supplier records for Icosapent Ethyl? 10 organisations hold a current record for Icosapent Ethyl: an active US FDA Type II Drug Master File. A further 2 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: China (4), South (1), Norway (1), France (1) and 1 other country (1); not recorded for 2.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Icosapent Ethyl: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/icosapent-ethyl
Reading the evidence
- 10 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Icosapent Ethyl expires 28 Jun 2033. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (10)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Icosapent Ethyl. Country is the organisation's recorded country, not necessarily the manufacturing site.
- SICHUAN GOWELL PHARMACEUTICAL CO LTDActive DMF 35854, 43834 · latest filing Mar 2026
- AK BIOPHARM CO., LTD.SouthActive DMF 36822 · latest filing Jun 2022
- BASF ASNorway Company GMP cert on recordActive DMF 23911 · latest filing Jul 2010
- CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTDCompany GMP cert on recordActive DMF 26271 · latest filing Aug 2012
- FINORGA SASFrance Company GMP cert on recordActive DMF 27182 · latest filing May 2013
- HUATAI PHARMA INCChinaActive DMF 34959 · latest filing Jul 2020
- JIANGSU HAINEKON BIOTECHNOLOGY CO LTDChinaActive DMF 36758 · latest filing Feb 2022
- KD PHARMA BEXBACH GMBHGermany Company GMP cert on recordActive DMF 26892 · latest filing Feb 2013
- KINOMEGA BIOPHARM INCChinaActive DMF 39040 · latest filing Oct 2023
- Zhejiang Medicine Co., Ltd.ChinaActive DMF 38870 · latest filing Oct 2023
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (2)
Organisations whose Type II DMFs for Icosapent Ethyl are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- Japan · Inactive DMF 30188 · filed Jun 2016
- SKUNY BIOSCIENCE CO LTDInactive DMF 28422 · filed Jun 2014
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (21 listed products contain Icosapent Ethyl). The latest listed patent expires 28 Jun 2033. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Icosapent Ethyl is an ethyl ester of eicosapentaenoic acid (EPA), an omega-3 fatty acid that is used to lower triglyceride levels in adults with severe hypertriglyceridemia. It is a prescription medication that has been shown to reduce the risk of cardiovascular events.
Chemical identity
- IUPAC name
- ethyl (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
- Canonical SMILES
- CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC
- InChIKey
- SSQPWTVBQMWLSZ-AAQCHOMXSA-N
- Synonyms
- Vascepa API, amr 101, amr-101, amr101, eicosapentaenoic acid ethyl ester, epadel, ethyl icosapent, ethyl icosapentate, icosapent ethyl ester, nsc-759597, timnodonic acid ethyl ester, vascepa
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Icosapent Ethyl?
10 organisations hold an active US FDA Type II Drug Master File or a CEP for Icosapent Ethyl: SICHUAN GOWELL PHARMACEUTICAL CO LTD, AK BIOPHARM CO., LTD. (South), BASF AS (Norway), CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD, FINORGA SAS (France), HUATAI PHARMA INC (China), JIANGSU HAINEKON BIOTECHNOLOGY CO LTD (China) and KD PHARMA BEXBACH GMBH (Germany), and 2 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Icosapent Ethyl Drug Master Files are active?
SICHUAN GOWELL PHARMACEUTICAL CO LTD (DMF 35854, 43834), AK BIOPHARM CO., LTD. (DMF 36822), BASF AS (DMF 23911), CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD (DMF 26271), FINORGA SAS (DMF 27182), HUATAI PHARMA INC (DMF 34959), JIANGSU HAINEKON BIOTECHNOLOGY CO LTD (DMF 36758) and KD PHARMA BEXBACH GMBH (DMF 26892) and 2 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Icosapent Ethyl records mean?
2 organisations have only inactive Type II DMFs for Icosapent Ethyl. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does the FDA Orange Book list patents for products containing Icosapent Ethyl?
Yes. The latest patent listed for an approved US product containing Icosapent Ethyl expires 28 Jun 2033, across 21 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Icosapent Ethyl supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Icosapent Ethyl?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.